What happened
Aprogen Biologics disclosed convertible bonds to raise US$1.34M, about 7.8% of its market value.
For context, this raise equals about 7.8% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$1.34M |
| vs. market value | 7.8% |
| Filed | 2026-07-14, Material event report (rights offering) |
| Source | DART rcept 20260714000440 → open original filing |
Source: DART. Information only, not investment advice.